tiprankstipranks
MacroGenics price target raised to $14 from $12 at H.C. Wainwright
The Fly

MacroGenics price target raised to $14 from $12 at H.C. Wainwright

H.C. Wainwright analyst Robert Burns raised the firm’s price target on MacroGenics to $14 from $12 and keeps a Buy rating on the shares. The analyst finds lorigerlimab’s early Phase 1 castration-resistant prostate cancer data "encouraging."

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on MGNX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles